ImmunityBio, Inc.

IBRXReported to SECin USCIK 0001326110Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 20. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 20
Form 4 lines at ImmunityBio, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Selecky Christobel—Option exercisenothing paid124,414 sharesJul 6, 2026Selecky Christobelnothing paidExercise · Jul 6Option exercise124,414Jul 6, 2026
Selecky Christobel—Option exercisenothing paid35,064 sharesJul 6, 2026Selecky Christobelnothing paidExercise · Jul 6Option exercise35,064Jul 6, 2026
Selecky Christobel—Open-market sell$1,439,066159,478 sharesJul 6, 2026Selecky Christobel$1,439,066Sell · Jul 6Open-market sell159,478Jul 6, 2026
Selecky Christobel—Option exercise$371,998124,414 sharesJul 6, 2026Selecky Christobel$371,998Exercise · Jul 6Option exercise124,414Jul 6, 2026
Selecky Christobel—Option exercise$104,49135,064 sharesJul 6, 2026Selecky Christobel$104,491Exercise · Jul 6Option exercise35,064Jul 6, 2026